Susceptibility patterns of Staphylococcus aureus biofilms in diabetic foot infections

BMC Microbiology

Volumn 16, Issue 1, 2016, Pages

  Mottola, Carla ^a   Matias, Carina S ^a   Mendes, João J ^b   Melo Cristino, José ^c   Tavares, Luís ^a   Cavaco Silva, Patrícia ^d,e   Oliveira, Manuela ^a  

^a FACULDADE DE MEDICINA VETERINÁRIA   (Portugal)

^b HOSPITAL DE SANTA MARTA   (Portugal)

^c INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^d TechnoPhage SA   (Portugal)

^e INSTITUTO SUPERIOR DE CIÊNCIAS DA SAÚDE EGAS MONIZ   (Portugal)

Author keywords

Diabetic foot infections; MBEC; MBIC; Resistance genes; Staphylococcus aureus

Indexed keywords

CEFOXITIN; CEFTAROLINE; CIPROFLOXACIN; CLINDAMYCIN; DOXYCYCLINE; ERYTHROMYCIN; GENTAMICIN; LINEZOLID; MEROPENEM; VANCOMYCIN; ANTIINFECTIVE AGENT; BETA LACTAM; CEPHALOSPORIN DERIVATIVE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATION; BIOFILM; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC FOOT; HUMAN; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MONOTHERAPY; NONHUMAN; POLYMERASE CHAIN REACTION; STAPHYLOCOCCUS AUREUS; DRUG EFFECTS; GENETICS; GROWTH, DEVELOPMENT AND AGING; ISOLATION AND PURIFICATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PHYSIOLOGY; PROCEDURES; STAPHYLOCOCCAL INFECTIONS;

ANTI-BACTERIAL AGENTS; BETA-LACTAMS; BIOFILMS; CEPHALOSPORINS; DIABETIC FOOT; GENTAMICINS; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; POLYMERASE CHAIN REACTION; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 84978252735     PISSN: None     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/s12866-016-0737-0     Document Type: Article

References (48)

1. Spichler A, Hurwitz BL, Armstrong DG, Lipsky BA. Microbiology of diabetic foot infections: from Louis Pasteur to "crime scene investigation.". BMC Med. 2015;13:1-13.
2. Mendes JJ, Marques-Costa A, Vilela C, Neves J, Candeias N, Cavaco-Silva P, et al. Clinical and bacteriological survey of diabetic foot infections in Lisbon. Diabetes Res Clin Pract. 2012;95:153-61.
3. Lipsky BA, Richard J-L, Lavigne J-P. Diabetic foot ulcer microbiome: one small step for molecular microbiology... One giant leap for understanding diabetic foot ulcers? Diabetes. 2013;62:679-81.
4. Petrelli D, Repetto A, D'Ercole S, Rombini S, Ripa S, Prenna M, et al. Analysis of meticillin-susceptible and meticillin-resistant biofilm-forming Staphylococcus aureus from catheter infections isolated in a large Italian hospital. J Med Microbiol. 2008;57:364-72.
5. Rice LB. Antimicrobial resistance in gram-positive bacteria. Am J Infect Control. 2006;119:11-9.
6. Chan LC, Basuino L, Diep B, Hamilton S, Chatterjee SS, Chambers HF. Ceftobiprole- and ceftaroline-resistant methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2015;59:2960-3.
7. Scherr TD, Heim CE, Morrison JM, Kielian T. Hiding in Plain Sight: Interplay between Staphylococcal Biofilms and Host Immunity. Front Immunol. 2014;5:1-7.
8. Gordon RJ, Lowy FD. Pathogenesis of methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis. 2008;46 Suppl 5:S350-9.
9. Lister JL, Horswill AR. Staphylococcus aureus biofilms: recent developments in biofilm dispersal. Front Cell Infect Microbiol. 2014;4:178.
10. Kaplan JB. Antibiotic-induced biofilm formation. Int J Artif Organs. 2011;34:737-51.
11. Rohde H, Burandt EC, Siemssen N, Frommelt L, Burdelski C, Wurster S, et al. Polysaccharide intercellular adhesin or protein factors in biofilm accumulation of Staphylococcus epidermidis and Staphylococcus aureus isolated from prosthetic hip and knee joint infections. Biomaterials. 2007;28:1711-20.
12. Biswas R, Voggu L, Simon UK, Hentschel P, Thumm G, Götz F. Activity of the major staphylococcal autolysin Atl. FEMS Microbiol Lett. 2006;259:260-8.
13. Hussain M, Schäfer D, Juuti KM, Peters G, Haslinger-Löffler B, Kuusela PI, et al. Expression of Pls (plasmin sensitive) in Staphylococcus aureus negative for pls reduces adherence and cellular invasion and acts by steric hindrance. J Infect Dis. 2009;200:107-17.
14. Mottola C, Semedo-Lemsadeck T, Mendes JJ, Melo Cristino J, Cavaco Silva P, Tavares L, Oliveira M: Molecular typing, virulence traits and antimicrobial resistance of diabetic foot staphylococci. J Biomed Sci. 2016;23:33.
15. Clinical and Laboratory Standards Institute: M100-S23 Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Third Informational Supplement. 2013(January).
16. Ceri H, Olson M, Stremick C. The Calgary Biofilm Device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J Clin Microbiol. 1999.
17. LaPlante KL, Mermel LA. In vitro activities of telavancin and vancomycin against biofilm-producing Staphylococcus aureus, S. epidermidis, and Enterococcus faecalis strains. Antimicrob Agents Chemother. 2009;53:3166-9.
18. Pettit RK, Weber CA, Kean MJ, Hoffmann H, Pettit GR, Tan R, et al. Microplate Alamar blue assay for Staphylococcus epidermidis biofilm susceptibility testing. Antimicrob Agents. 2005;49:2612-7.
19. Cafiso V, Bertuccio T, Spina D, Purrello S, Stefani S. Tigecycline inhibition of a mature biofilm in clinical isolates of Staphylococcus aureus: comparison with other drugs. FEMS Immunol Med Microbiol. 2010;59:466-9.
20. Coraça-Huber DC, Fille M, Hausdorfer J, Pfaller K, Nogler M. Staphylococcus aureus biofilm formation and antibiotic susceptibility tests on polystyrene and metal surfaces. J Appl Microbiol. 2012;112:1235-43.
21. Pettit RK, Weber CA, Pettit GR. Application of a high throughput Alamar blue biofilm susceptibility assay to Staphylococcus aureus biofilms. Ann Clin Microbiol Antimicrob. 2009;8:28.
22. Harrison JJ. Stremick C a, Turner RJ, Allan ND, Olson ME, Ceri H: Microtiter susceptibility testing of microbes growing on peg lids: a miniaturized biofilm model for high-throughput screening. Nat Protoc. 2010;5:1236-54.
23. Mottola C, Mendes JJ, Cristino JM, Cavaco-Silva P, Tavares L, Oliveira M. Polymicrobial biofilms by diabetic foot clinical isolates. Folia Microbiol (Praha). 2015;61 Suppl 1:35-43.
24. Stegger M, Andersen PS, Kearns A, Pichon B, Holmes MA, Edwards G, et al. Rapid detection, differentiation and typing of methicillin-resistant Staphylococcus aureus harbouring either mecA or the new mecA homologue mecA LGA251. Clin Microbiol Infect. 2012;18:395-400.
25. Neut D. Tijdens-Creusen EJ a, Bulstra SK, van der Mei HC, Busscher HJ: Biofilms in chronic diabetic foot ulcers - a study of 2 cases. Acta Orthop. 2011;82:383-5.
26. Savolainen K, Paulin L, Westerlund-wikstrom B, Foster T, Korhonen TK, Kuusela P. Expression of pls, a Gene Closely Associated with the mecA Gene of Methicillin-Resistant Staphylococcus aureus, Prevents Bacterial Adhesion In Vitro. Microbiology. 2001;69:3013-20.
27. Patel R. Biofilms and Antimicrobial Resistance. Clin Orthop Relat Res. 2005;437:41-7.
28. Siripornmongcolchai T, Chomvarin C, Chaicumpar K, Limpaiboon T, Wongkhum C. Evaluation of different primers for detecting mecA gene by PCR in comparison with phenotypic methods for discrimination of methicillin-resistant Staphylococcus aureus. Southeast Asian J ournal Trop Med Public Heal. 2002;33:758-63.
29. García-Álvarez L, Holden MTG, Lindsay H, Webb CR, Brown DFJ, Curran MD, et al. Meticillin-resistant Staphylococcus aureus with a novel mecA homologue in human and bovine populations in the UK and Denmark: A descriptive study. Lancet Infect Dis. 2011;11:595-603.
30. Paterson GK, Harrison EM. Holmes M a.: The emergence of mecC methicillin-resistant Staphylococcus aureus. Trends Microbiol. 2014;22:42-7.
31. Bowling FL, Jude EB, Boulton AJM. MRSA and diabetic foot wounds: contaminating or infecting organisms? Curr Diab Rep. 2009;9:440-4.
32. Djahmi N, Messad N, Nedjai S, Moussaoui A, Mazouz D, Richard J, et al. Molecular epidemiology of Staphylococcus aureus strains isolated from inpatients with infected diabetic foot ulcers in an Algerian University Hospital. Clin Microbiol Infect. 2013;19:E398-404.
33. Pereira LA, Harnett GB, Hodge MM, Cattell JA, Speers DJ. Real-time PCR assay for detection of blaZ genes in Staphylococcus aureus clinical isolates. J Clin Microbiol. 2014;52:1259-61.
34. El Feghaly RE, Stamm JE. Fritz S a., Burnham CAD: Presence of the blaZ beta-lactamase gene in isolates of Staphylococcus aureus that appear penicillin susceptible by conventional phenotypic methods. Diagn Microbiol Infect Dis. 2012;74:388-93.
35. Barber KE, Smith JR, Ireland CE, Boles BR, Rose WE, Rybak MJ: Evaluation of Ceftaroline Alone and in Combination Against Biofilm-producing 1 Methicillin-resistant Staphylococcus aureus (MRSA) with Reduced Susceptibility to 2 daptomycin and vancomycin in an In Vitro Pharmacokinetic/Pharmacodynamic Model. Antimicrob Agents Chemother 2015(May).
36. Barber KE, Werth BJ, McRoberts JP, Rybak MJ. A Novel Approach Utilizing Biofilm Time Kill Curves in Assessing the Bactericidal Activity of Ceftaroline Combinations Against Biofilm Producing Methicillin-Resistant Staphylococcus aureus (MRSA). Antimicrob Agents Chemother. 2014;58:2989-92.
37. Kotulová D, Slobodníková L. Susceptibility of Staphylococcus aureus biofilms to vancomycin, gemtamicin and rifampin. Epidemiol Mikrobiol Imunol. 2010;59:80-7.
38. Martineau F, Picard FJ, Lansac N, Ménard C, Roy PH, Ouellette M, et al. Correlation between the resistance genotype determined by multiplex PCR assays and the antibiotic susceptibility patterns of Staphylococcus aureus and Staphylococcus epidermidis. Antimicrob Agents Chemother. 2000;44:231-8.
39. Smith K, Perez A, Ramage G, Gemmell CG, Lang S. Comparison of biofilm-associated cell survival following in vitro exposure of meticillin-resistant Staphylococcus aureus biofilms to the antibiotics clindamycin, daptomycin, linezolid, tigecycline and vancomycin. Int J Antimicrob Agents. 2009;33:374-8.
40. Rose WE, Poppens PT. Impact of biofilm on the in vitro activity of vancomycin alone and in combination with tigecycline and rifampicin against Staphylococcus aureus. J Antimicrob Chemother. 2009;63:485-8.
41. Strommenger B, Kettlitz C, Werner G. Multiplex PCR assay for simultaneous detection of nine clinically relevant antibiotic resistance genes in Staphylococcus aureus. J Clin Microbiol. 2003;41:4089-94.
42. Werner G, Cuny C, Schmitz F. Staphylococcus aureus with Reduced Sensitivity to Glycopeptides. J Clin Microbiol. 2001;39:3586-90.
43. Jv S, Janakiram K, Vijaya D. Inducible clindamycin resistance in Staphylococcus aureus: Reason for treatment failure. J Int Med Dent. 2015;2:97-103.
44. Andersen JL, He GX, Kakarla P, Ranjana KC, Kumar S, Lakra WS, et al. Multidrug efflux pumps from enterobacteriaceae, Vibrio cholerae and Staphylococcus aureus bacterial food pathogens. Int J Environ Res Public Health. 2015;12:1487-547.
45. Trzcinski K, Cooper BS, Hryniewicz W, Dowson CG. Expression of resistance to tetracyclines in strains of methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother. 2000;45:763-70.
46. Arciola CR, Baldassarri L, Montanaro L. Presence of icaA and icaD genes and slime production in a collection of staphylococcal strains from catheter-associated infections. J Clin Microbiol. 2001;39:2151-6.
47. Ng LK, Martin I, Alfa M, Mulvey M. Multiplex PCR for the detection of tetracycline resistant genes. Mol Cell Probes. 2001;15:209-15.
48. Pourmand MR, Yousefi M, Salami SA, Amini M. Evaluation of Expression of NorA Efflux Pump in Ciprofloxacin Resistant Staphylococcus aureus against Hexahydroquinoline Derivative by Real-Time PCR. Acta Med Iran. 2014;52:424-9.